Nalaganje...
Epirubicin extravasation: consequences of delayed management
Epirubicin is an anthracycline chemotherapy agent used for treatment of several cancers including oesophageal, breast and gastric. Extravasation is a well-recognised and serious complication of any intravenous therapies but especially chemotherapeutic agents. Signs of the injury can be subtle and wi...
Shranjeno v:
| izdano v: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256447/ https://ncbi.nlm.nih.gov/pubmed/28062432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-218012 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|